Clinical Variants of Acute Hepatitis A
Acute hepatitis A typically presents as a self-limited illness, but clinicians must recognize several important clinical variants including relapsing hepatitis (10-15% of cases), prolonged cholestasis, fulminant hepatic failure (<1%), and rare extrahepatic manifestations. 1, 2
Primary Clinical Variants
1. Classic Acute Hepatitis (Most Common)
The typical presentation includes:
- Abrupt onset after 28-day incubation (range 15-50 days)
- Prodromal symptoms: fever, malaise, anorexia, nausea, abdominal discomfort
- Dark urine followed by jaundice
- Peak infectivity occurs 2 weeks before jaundice onset
- Duration typically <2 months with complete recovery 1, 3
Age-dependent severity: Children <6 years have 70% asymptomatic infections, while >70% of adults develop jaundice 1, 3
2. Relapsing Hepatitis (10-15% of Cases)
This variant presents with:
- Initial resolution of symptoms and normalization of liver enzymes
- Recurrence within 6 months of initial illness
- Biphasic pattern with return of jaundice, elevated transaminases
- Recurrent viral shedding in stool during relapses
- Generally benign course with eventual complete recovery 1, 2, 4
Clinical pitfall: The relapsing form can be mistaken for a new infection or chronic hepatitis. Maintain clinical suspicion when symptoms recur after apparent resolution.
3. Prolonged Cholestatic Variant
Characterized by:
- Persistent jaundice lasting >3 months
- Marked hyperbilirubinemia (can exceed 50 mg/dL)
- Intense pruritus as dominant symptom
- Minimal elevation of transaminases relative to bilirubin
- Clay-colored stools persisting beyond typical 2-3 week period 2, 5, 4
Management consideration: Symptomatic patients may benefit from ursodeoxycholic acid or short-course corticosteroids, though evidence is limited 4
4. Acute Liver Failure (<1% of Cases)
The most severe variant with:
- Development of hepatic encephalopathy
- Coagulopathy (INR >1.5)
- Overall case-fatality rate 0.3-0.6%, but reaches 1.8% in adults >50 years
- Higher risk in patients with preexisting chronic liver disease
- Requires urgent liver transplant evaluation 6, 1, 2, 7
Critical distinction: Fulminant hepatitis A is rare but represents a medical emergency requiring immediate referral to a transplant center.
5. Extrahepatic Manifestations (Rare)
Uncommon variants include:
- Hematologic: Autoimmune hemolytic anemia, aplastic anemia, pure red cell aplasia (often associated with G6PD deficiency)
- Rheumatologic: Polyarthralgia affecting small joints without arthritis, acute reactive arthritis
- Dermatologic: Maculopapular or pruritic rash
- Neurologic: Guillain-Barré syndrome, mononeuritis
- Other organs: Acute pancreatitis, acalculous cholecystitis, pleural/pericardial effusion 8, 2, 5
Diagnostic challenge: These extrahepatic features may precede or overshadow hepatic symptoms, potentially delaying diagnosis 8
Diagnostic Considerations
Serologic Testing Nuances
- IgM anti-HAV is diagnostic of acute infection and becomes detectable 5-10 days before symptom onset in most patients 1
- Critical caveat: Rare cases may test negative for IgM anti-HAV at initial presentation despite active symptoms, requiring repeat testing days later 8
- IgM typically declines to undetectable levels within 6 months but can persist >1 year in some patients 1
- False-positive IgM results have been reported in persons without recent HAV infection 1
Histologic Patterns
When liver biopsy is performed (rarely necessary):
- Classic acute hepatitis pattern with portal inflammation
- Centrilobular (zone 3) necrosis may be prominent
- Cholestatic variant shows bile plugging and ductular reaction
- No progression to chronic hepatitis or fibrosis occurs 2
Key Clinical Pitfalls to Avoid
Don't dismiss the diagnosis based on single negative IgM anti-HAV: Repeat testing in 3-7 days if clinical suspicion remains high 8
Don't assume all jaundice >2 months indicates chronic liver disease: Prolonged cholestatic hepatitis A can mimic biliary obstruction or chronic hepatitis but eventually resolves 2, 4
Don't overlook HAV in patients with extrahepatic manifestations: Arthralgia, rash, or hematologic abnormalities may dominate the clinical picture before hepatitis becomes apparent 8, 5
Don't delay transplant evaluation in deteriorating patients: Any patient developing encephalopathy requires immediate referral regardless of initial severity 6, 7
Recognize higher risk populations: Adults >40-50 years and those with preexisting chronic liver disease (including chronic hepatitis B or C) have significantly worse outcomes 2, 5
Prognostic Factors
Favorable prognosis: Younger age, absence of underlying liver disease, prompt supportive care
Poor prognosis indicators: